Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.24
-0.04 (-3.13%)
At close: Aug 19, 2025, 3:59 PM
1.28
3.34%
Pre-market: Aug 20, 2025, 08:00 AM EDT
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a 6.19% growth. For the quarter ending June 30, 2025, Lineage Cell Therapeutics generated $2.77M in revenue.
Revenue (ttm)
9.5M
Revenue Growth
6.19%
Price / Sales Ratio
10.59
Revenue / Employee
135.7K
Employees
70
Market Cap
283.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.5M | +6.19% |
| Dec 31, 2023 | 8.95M | -39.16% |
| Dec 31, 2022 | 14.7M | +277.39% |
| Dec 31, 2021 | 3.9M | +404.01% |
| Dec 31, 2020 | 773K | -47.70% |
| Dec 31, 2019 | 1.48M | +4.38% |
| Dec 31, 2018 | 1.42M | -20.98% |
| Dec 31, 2017 | 1.79M | -20.43% |
| Dec 31, 2016 | 2.25M | -11.13% |
| Dec 31, 2015 | 2.53M | +30.19% |
| Dec 31, 2014 | 1.95M | -31.97% |
| Dec 31, 2013 | 2.86M | +69.00% |
| Dec 31, 2012 | 1.69M | -61.13% |
| Dec 31, 2011 | 4.35M | +18.33% |
| Dec 31, 2010 | 3.68M | +91.17% |
| Dec 31, 2009 | 1.93M | +28.02% |
| Dec 31, 2008 | 1.5M | +43.75% |
| Dec 31, 2007 | 1.05M | -9.97% |
| Dec 31, 2006 | 1.16M | +28.66% |
| Dec 31, 2005 | 903.2K | +31.21% |
| Dec 31, 2004 | 688.38K | +23.71% |
| Dec 31, 2003 | 556.42K | +43.77% |
| Dec 31, 2002 | 387.02K | +154.76% |
| Dec 31, 2001 | 151.92K | +189.41% |
| Dec 31, 2000 | 52.49K | -94.94% |
| Dec 31, 1999 | 1.04M | +245.83% |
| Dec 31, 1998 | 300K | +200.00% |
| Jun 30, 1998 | 100K | n/a |
| Jun 30, 1996 | 100K | n/a |
| Jun 30, 1995 | 100K | n/a |
| Jun 30, 1994 | 100K | n/a |
| Jun 30, 1993 | 100K | n/a |
| Jun 30, 1992 | 100K | n/a |